(Q37910709)

25 August 2017

1 reference

title

Urological aspects of the metabolic syndrome (English)

1 reference

25 August 2017

1 reference

Jan Hammarsten

1

1 reference

25 August 2017

Ralph Peeker

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

2 August 2011

1 reference

25 August 2017

published in

Nature Reviews Urology

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

9

1 reference

25 August 2017

page(s)

483-494

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

25 August 2017

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Metabolic factors associated with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prostate cancer: another aspect of the insulin-resistance syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Nutrition, insulin, insulin-like growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Insulin-resistance and benign prostatic hyperplasia: the connection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Insulin resistance and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Body mass index as a predictor of prostate cancer: development versus detection on biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Racial differences in risk of prostate cancer associated with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

The metabolic syndrome is associated with reduced risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Sex hormones, inflammation and the metabolic syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Obesity and prostate cancer: making sense out of apparently conflicting data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Obesity is a significant risk factor for prostate cancer at the time of biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

The emerging link between hypogonadism and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

The role of estradiol in the maintenance of secondary hypogonadism in males in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Time trends in reported prevalence of kidney stones in the United States: 1976-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Recent advances in the pathophysiology of nephrolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Biochemical profile of stone-forming patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Diabetes mellitus and the risk of nephrolithiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Kidney stone disease and risk factors for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Obesity, weight gain, and the risk of kidney stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

A prospective study of hypertension and the incidence of kidney stones in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

The association of nephrolithiasis with hypertension and obesity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Metabolic effects of fructose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Bladder dysfunction in rats with metabolic syndrome induced by long-term fructose feeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Alterations of M2,3-muscarinic receptor protein and mRNA expression in the bladder of the fructose fed obese rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Type 2 diabetes mellitus and risk of stress, urge and mixed urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Pelvic floor disorders, diabetes, and obesity in women: findings from the Kaiser Permanente Continence Associated Risk Epidemiology Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms of Males and Females in the Aspect of Gender-Specific Medicine: A Single Institutional Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

The worldwide prevalence and epidemiology of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Is type 2 diabetes mellitus a cause of severe erectile dysfunction in patients with metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Predictors and prevalence of erectile dysfunction in a racially diverse population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prevalence of erectile dysfunction in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Screening for ischemic heart disease in patients with erectile dysfunction: role of penile Doppler ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Coronary artery risk factors in patients with erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Sexual response in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Correlation between penile duplex findings and stress electrocardiography in men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Combined cardiac sympathetic excitation and vagal impairment in patients with non-organic erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Observational multicentric trial performed with doxazosin: evaluation of sexual effects on patients with diagnosed benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Metabolic sequelae associated with androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Trends in hyperinsulinemia among nondiabetic adults in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

State of the epidemiological evidence on physical activity and cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Carbohydrate for weight and metabolic control: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Features of the metabolic syndrome and prostate cancer in African-American men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prospective analysis of the insulin-resistance syndrome (syndrome X).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Increased serum insulin associated with increased risk of prostate cancer recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Relationship between prostate-specific antigen and hematocrit: does hemodilution lead to lower PSA concentrations in men with a higher body mass index?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Obesity in men: the hypogonadal-estrogen receptor relationship and its effect on glucose homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Nephrolithiasis is associated with an increased prevalence of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Association between lower urinary tract symptoms and erectile dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.112

Blood pressure and endogenous testosterone in men: an inverse relationship

31 March 2020

1 reference

12 December 2020

[Association study between benign prostatic hyperplasia and primary hypertension]

1 reference

12 December 2020

Leptin is associated with increased prostate cancer risk: a nested case-referent study

1 reference

12 December 2020

Syndrome X: 6 years later

1 reference

12 December 2020

[Correlation of benign prostatic hyperplasia with hyperlipemia]

1 reference

12 December 2020

Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia

1 reference

12 December 2020

Urodynamics in benign prostatic hyperplasia: a survey.

1 reference

12 December 2020

Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men.

1 reference

12 December 2020

Androgenic regulation of NO availability in rat penile erection

1 reference

12 December 2020

Body size and risk of kidney stones.

1 reference

12 December 2020

Metabolic syndrome and urologic diseases

1 reference

12 December 2020

Body size and composition and prostate cancer risk.

1 reference

12 December 2020

Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2011.112

1 reference

Dimensions Publication ID

25 August 2017

1005735210

0 references

1 reference